| BRD2 |
BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 |
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
6.392 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
6.392 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
ERCC3 |
ERCC3, XPB, XPBC: TFIIH basal transcription factor complex helicase XPB subunit |
6.392 |
Evidence |
|
| MAPK13 |
MAPK13, PRKM13, SAPK4: Mitogen-activated protein kinase 13 |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
6.392 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
6.392 |
Evidence |
|
| ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
BICD2 |
BICD2, KIAA0699: Protein bicaudal D homolog 2 |
6.387 |
Evidence |
|
| ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
BICD2 |
BICD2, KIAA0699: Protein bicaudal D homolog 2 |
6.387 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
PLD1 |
PLD1: Phospholipase D1 |
6.385 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
6.385 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
6.382 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
6.382 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
6.382 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
DLG2 |
DLG2: Disks large homolog 2 |
6.382 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
6.382 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
6.382 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
6.382 |
Evidence |
O
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
6.38 |
Evidence |
|
| MTA2 |
MTA1L1, MTA2, PID: Metastasis-associated protein MTA2 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
6.38 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
6.377 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
6.377 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
CHC1 |
RCC1: RCC1-I (Fragment) |
6.375 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
6.375 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
ALCAM |
ALCAM, MEMD: CD166 antigen precursor |
6.37 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
6.37 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
6.37 |
Evidence |
|
- 
-